Health Care & Life Sciences » Pharmaceuticals | Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc. | Ownership

Companies that own Rigel Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Management & Research Co.
24,537,044
14.74%
2,448,925
0.01%
06/30/2018
Wellington Management Co. LLP
22,483,640
13.51%
1,872,185
0.01%
06/30/2018
BlackRock Fund Advisors
12,205,748
7.33%
1,866,470
0%
06/30/2018
SSgA Funds Management, Inc.
7,995,273
4.8%
2,996,864
0%
06/30/2018
The Vanguard Group, Inc.
7,047,624
4.23%
793,003
0%
06/30/2018
Citadel Advisors LLC
6,167,804
3.71%
3,014,348
0.03%
06/30/2018
OppenheimerFunds, Inc.
5,000,000
3%
-13,679
0.01%
06/30/2018
Marshall Wace North America LP
4,177,921
2.5%
1,151,725
0.08%
06/30/2018
Palo Alto Investors LP
3,966,087
2.38%
0
0.52%
06/30/2018
Rock Springs Capital Management LP
3,950,000
2.37%
1,375,000
0.49%
06/30/2018

About Rigel Pharmaceuticals

View Profile
Address
1180 Veterans Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.rigel.com
Updated 07/08/2019
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. It focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.